Frédéric Vigant

1.4k total citations
22 papers, 800 citations indexed

About

Frédéric Vigant is a scholar working on Genetics, Molecular Biology and Epidemiology. According to data from OpenAlex, Frédéric Vigant has authored 22 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Frédéric Vigant's work include Virus-based gene therapy research (10 papers), Virology and Viral Diseases (6 papers) and CAR-T cell therapy research (5 papers). Frédéric Vigant is often cited by papers focused on Virus-based gene therapy research (10 papers), Virology and Viral Diseases (6 papers) and CAR-T cell therapy research (5 papers). Frédéric Vigant collaborates with scholars based in United States, France and Portugal. Frédéric Vigant's co-authors include Benhur Lee, Nuno C. Santos, Karim Benihoud, Arnold Park, Michael E. Jung, Sohui T. Won, Patrick Hong, Alexander N. Freiberg, Michel Perricaudet and Olivier Pernet and has published in prestigious journals such as PLoS ONE, Hepatology and Nature Reviews Microbiology.

In The Last Decade

Frédéric Vigant

20 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Vigant United States 15 306 253 214 202 192 22 800
Stephanie Erbar Germany 13 524 1.7× 238 0.9× 418 2.0× 187 0.9× 246 1.3× 16 919
B. Precious United Kingdom 15 250 0.8× 350 1.4× 178 0.8× 142 0.7× 246 1.3× 15 668
Gualtiero Alvisi Italy 23 618 2.0× 432 1.7× 240 1.1× 240 1.2× 128 0.7× 56 1.3k
Anasuya Chattopadhyay United States 21 295 1.0× 347 1.4× 297 1.4× 108 0.5× 74 0.4× 29 784
Jaya Rajaiya United States 20 400 1.3× 325 1.3× 295 1.4× 619 3.1× 224 1.2× 44 1.1k
Emily M. Plummer United States 14 256 0.8× 158 0.6× 300 1.4× 99 0.5× 161 0.8× 17 920
Johann Mols Belgium 11 558 1.8× 439 1.7× 141 0.7× 115 0.6× 307 1.6× 16 1.2k
Maureen F. Maughan United States 12 268 0.9× 253 1.0× 314 1.5× 141 0.7× 360 1.9× 17 840
Franck Lemiale United States 12 395 1.3× 152 0.6× 217 1.0× 383 1.9× 211 1.1× 19 863
Heather J. Ezelle United States 16 353 1.2× 327 1.3× 129 0.6× 138 0.7× 389 2.0× 21 1.0k

Countries citing papers authored by Frédéric Vigant

Since Specialization
Citations

This map shows the geographic impact of Frédéric Vigant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Vigant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Vigant more than expected).

Fields of papers citing papers by Frédéric Vigant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Vigant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Vigant. The network helps show where Frédéric Vigant may publish in the future.

Co-authorship network of co-authors of Frédéric Vigant

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Vigant. A scholar is included among the top collaborators of Frédéric Vigant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Vigant. Frédéric Vigant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Beaty, Shannon M., Raffael Nachbagauer, Ariana Hirsh, et al.. (2016). Cross-reactive and cross-neutralizing activity of human mumps antibodies against a novel mumps virus from bats. The Journal of Infectious Diseases. 215(2). jiw534–jiw534. 8 indexed citations
4.
Vigant, Frédéric, Orianne Wagner‐Ballon, Stéphane Giraudier, et al.. (2016). Pseudotyping Serotype 5 Adenovirus with the Fiber from Other Serotypes Uncovers a Key Role of the Fiber Protein in Adenovirus 5-Induced Thrombocytopenia. Human Gene Therapy. 27(2). 193–201. 7 indexed citations
5.
Schwarz, Toni M., et al.. (2016). The Microtubule Inhibitor Podofilox Inhibits an Early Entry Step of Human Cytomegalovirus. Viruses. 8(10). 295–295. 17 indexed citations
6.
Park, Arnold, Patrick Hong, Sohui T. Won, et al.. (2016). Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editing. Molecular Therapy — Methods & Clinical Development. 3. 16057–16057. 47 indexed citations
7.
Park, Arnold, Tatyana Yun, Frédéric Vigant, et al.. (2016). Nipah Virus C Protein Recruits Tsg101 to Promote the Efficient Release of Virus in an ESCRT-Dependent Pathway. PLoS Pathogens. 12(5). e1005659–e1005659. 33 indexed citations
8.
Lee, Jihye, Frédéric Vigant, Benhur Lee, et al.. (2016). Inhibition of an Aquatic Rhabdovirus Demonstrates Promise of a Broad-Spectrum Antiviral for Use in Aquaculture. Journal of Virology. 91(4). 33 indexed citations
9.
Benihoud, Karim, Frédéric Vigant, Christoph Q. Schmidt, et al.. (2015). Hexon Modification to Improve the Activity of Oncolytic Adenovirus Vectors against Neoplastic and Stromal Cells in Pancreatic Cancer. PLoS ONE. 10(2). e0117254–e0117254. 17 indexed citations
10.
Vigant, Frédéric, Nuno C. Santos, & Benhur Lee. (2015). Broad-spectrum antivirals against viral fusion. Nature Reviews Microbiology. 13(7). 426–437. 194 indexed citations
11.
Vigant, Frédéric, Axel Hollmann, Jihye Lee, et al.. (2013). The Rigid Amphipathic Fusion Inhibitor dUY11 Acts through Photosensitization of Viruses. Journal of Virology. 88(3). 1849–1853. 60 indexed citations
12.
Vigant, Frédéric, Ben Van Handel, Olivier Pernet, et al.. (2013). Nipah Virus Envelope-Pseudotyped Lentiviruses Efficiently Target ephrinB2-Positive Stem Cell Populations In Vitro and Bypass the Liver Sink When Administered In Vivo. Journal of Virology. 87(8). 4794–4794. 1 indexed citations
13.
Vigant, Frédéric, Ben Van Handel, Olivier Pernet, et al.. (2012). Nipah Virus Envelope-Pseudotyped Lentiviruses Efficiently Target ephrinB2-Positive Stem Cell Populations In Vitro and Bypass the Liver Sink When Administered In Vivo. Journal of Virology. 87(4). 2094–2108. 34 indexed citations
14.
Vigant, Frédéric & Benhur Lee. (2011). Hendra and Nipah Infection: Pathology, Models and Potential Therapies. Infectious Disorders - Drug Targets. 11(3). 315–336. 29 indexed citations
15.
Vigant, Frédéric, Michael E. Jung, & Benhur Lee. (2010). Positive Reinforcement for Viruses. Chemistry & Biology. 17(10). 1049–1051. 11 indexed citations
16.
Franciszkiewicz, Katarzyna, Audrey Le Floc’h, Abdelali Jalil, et al.. (2009). Intratumoral Induction of CD103 Triggers Tumor-Specific CTL Function and CCR5-Dependent T-Cell Retention. Cancer Research. 69(15). 6249–6255. 73 indexed citations
17.
Vigant, Frédéric, Erika Muth, Ronan Chaligné, et al.. (2009). Efficient delivery of angiostatin K1-5 into tumors following insertion of an NGR peptide into adenovirus capsid. Gene Therapy. 16(12). 1405–1415. 16 indexed citations
18.
Vigant, Frédéric, Delphyne Descamps, Elisabeth Connault, et al.. (2008). Substitution of Hexon Hypervariable Region 5 of Adenovirus Serotype 5 Abrogates Blood Factor Binding and Limits Gene Transfer to Liver. Molecular Therapy. 16(8). 1474–1480. 75 indexed citations
19.
Descamps, Delphyne, Frédéric Vigant, Elisabeth Connault, et al.. (2006). Expression of non-signaling membrane-anchored death receptors protects murine livers in different models of hepatitis. Hepatology. 44(2). 399–409. 5 indexed citations
20.
Gastinne, Thomas, Frédéric Vigant, Cécile Lavenu‐Bombled, et al.. (2006). Adenoviral-mediated TGF-β1 inhibition in a mouse model of myelofibrosis inhibit bone marrow fibrosis development. Experimental Hematology. 35(1). 64–74. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephanie Erbar Breakdown of academic impact, for papers by B. Precious Breakdown of academic impact, for papers by Gualtiero Alvisi Breakdown of academic impact, for papers by Anasuya Chattopadhyay Breakdown of academic impact, for papers by Jaya Rajaiya Breakdown of academic impact, for papers by Emily M. Plummer Breakdown of academic impact, for papers by Johann Mols Breakdown of academic impact, for papers by Maureen F. Maughan Breakdown of academic impact, for papers by Franck Lemiale Breakdown of academic impact, for papers by Heather J. Ezelle
Rankless by CCL
2026